Will Earnings Beat Estimates? Nucor Corp. (NUE) Stock

Citigroup raised the price target for the Nucor Corp. (NYSE:NUE) stock from “a Neutral” to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $151. The stock was upgraded by Exane […]

Are Nucor Corp.’s (NUE) stock prices rising too high?

Citigroup raised the price target for the Nucor Corp. (NYSE:NUE) stock from “a Neutral” to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $151. The stock was upgraded by Exane […]

Invest in Nucor Corp. (NUE) Stock with the prospect of future returns

Citigroup raised the price target for the Nucor Corp. (NYSE:NUE) stock from “a Neutral” to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $151. The stock was upgraded by Exane […]

Nucor Corp. (NUE) Stock Is Emerging from the Clouds

Citigroup raised the price target for the Nucor Corp. (NYSE:NUE) stock from “a Neutral” to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $151. The stock was upgraded by Exane […]

upgraded: Citigroup Recommends Nucor Corp. (NYSE:NUE) Stock to “a Buy”

Citigroup raised the price target for the Nucor Corp. (NYSE:NUE) stock from “a Neutral” to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $151. The stock was upgraded by Exane […]

Earnings and valuation of Nucor Corp. (NUE) Stock are impressive

Citigroup raised the price target for the Nucor Corp. (NYSE:NUE) stock from “a Neutral” to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $151. The stock was upgraded by Exane […]